These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19523464)

  • 81. Method comparison for CA 15-3, CA 19-9, and CA 125 determination using the new LOCI technique of Dimension Vista 1500 and Immulite 2000 XPI.
    Zur B; Holdenrieder S; Albers E; Walgenbach-Brünagel G; Stoffel-Wagner B
    J Immunoassay Immunochem; 2012; 33(4):435-45. PubMed ID: 22963492
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Two-dimensional paper chromatography-based fluorescent immunosensor for detecting acute myocardial infarction markers.
    Cho JH; Kim MH; Mok RS; Jeon JW; Lim GS; Chai CY; Paek SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 967():139-46. PubMed ID: 25089959
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lab-on-a-disc for fully integrated multiplex immunoassays.
    Park J; Sunkara V; Kim TH; Hwang H; Cho YK
    Anal Chem; 2012 Mar; 84(5):2133-40. PubMed ID: 22277086
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Ultra-endurance exercise in a heart transplant athlete: Influence on myocardial function and biomarkers.
    Esefeld K; Fricke H; Haykowsky M; Halle M
    Eur J Prev Cardiol; 2020 May; 27(8):885-887. PubMed ID: 30396292
    [No Abstract]   [Full Text] [Related]  

  • 85. Evaluation of the new ImmuliteTurbo cTnI assay and the original immulite cTnI assay.
    Peetz D; Erbes H; Hafner G
    Scand J Clin Lab Invest; 2001; 61(8):593-601. PubMed ID: 11768318
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Assay performance improved, but which "scorecard" designation for Vitros Troponin I?
    Zaninotto M; Vernocchi A; Di Serio F; Viloria Mdel M; Hurtado JM; Perez-Guerrero JJ; Plebani M
    Clin Chim Acta; 2012 Apr; 413(7-8):826-8. PubMed ID: 22301372
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Response to the comment on "Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure".
    Flores-Solís LM; Hernández-Domínguez JL; Otero-González A; González-Juanatey JR
    Nefrologia; 2013 Nov; 33(6):852-3. PubMed ID: 24241374
    [No Abstract]   [Full Text] [Related]  

  • 88. Comment on "Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure".
    Cakar M
    Nefrologia; 2013 Nov; 33(6):852. PubMed ID: 24241375
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Detection of cardiac biomarkers using single polyaniline nanowire-based conductometric biosensors.
    Lee I; Luo X; Huang J; Cui XT; Yun M
    Biosensors (Basel); 2012 May; 2(2):205-20. PubMed ID: 25585711
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effects of the whole-body cryotherapy on NTproBNP, hsCRP and troponin I in athletes.
    Banfi G; Melegati G; Barassi A; d'Eril GM
    J Sci Med Sport; 2009 Nov; 12(6):609-10. PubMed ID: 18835219
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Multimarker approach in risk stratification of patients with acute coronary syndromes: towards the ideal stratification.
    Silva D
    Rev Port Cardiol; 2014 Mar; 33(3):137-8. PubMed ID: 24680557
    [No Abstract]   [Full Text] [Related]  

  • 92. Glucose-lowering targets for patients with cardiovascular disease: focus on inpatient management of patients with acute coronary syndromes.
    Kosiborod M; McGuire DK
    Circulation; 2010 Dec; 122(25):2736-44. PubMed ID: 21173362
    [No Abstract]   [Full Text] [Related]  

  • 93. Understanding cardiovascular biomarkers.
    Hieronymus L; Wortzman-Show G
    Diabetes Self Manag; 2013; 30(3):16, 18-20. PubMed ID: 23951629
    [No Abstract]   [Full Text] [Related]  

  • 94. The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?
    Tello-Montoliu A; Marín F; Roldán V; Lip GY
    Heart; 2010 Feb; 96(3):227-8; author reply 228. PubMed ID: 20133421
    [No Abstract]   [Full Text] [Related]  

  • 95. A New Hematocrit Measurement Method Using a Chemiluminescence Biosensor and Its Application in a Chemiluminescence Immunoassay Platform for Myocardial Markers Detection with Whole Blood Samples.
    Zhao H; Han H; Lin Q; Huang L; Su X; Fang Y; Zhang Y; Su E; Chen Z; Li S; Deng Y; He N
    Biosensors (Basel); 2022 Dec; 13(1):. PubMed ID: 36671839
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A systematic evaluation of immunoassay point-of-care testing to define impact on patients' outcomes.
    Pecoraro V; Banfi G; Germagnoli L; Trenti T
    Ann Clin Biochem; 2017 Jul; 54(4):420-431. PubMed ID: 28135840
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ultrasensitive flow-based immunoassays using single-molecule counting.
    Todd J; Freese B; Lu A; Held D; Morey J; Livingston R; Goix P
    Clin Chem; 2007 Nov; 53(11):1990-5. PubMed ID: 17890441
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Silicon nanosensor for diagnosis of cardiovascular proteomic markers.
    Prasad S; Selvam AP; Reddy RK; Love A
    J Lab Autom; 2013 Apr; 18(2):143-51. PubMed ID: 23015518
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Biomarkers in risk stratification of acute coronary syndromes: new insights into hematologic parameters.
    Gavina C
    Rev Port Cardiol; 2009 Sep; 28(9):925-7. PubMed ID: 19998804
    [No Abstract]   [Full Text] [Related]  

  • 100. Role of Salivary Biomarkers in Detection of Cardiovascular Diseases (CVD).
    Abdul Rehman S; Khurshid Z; Hussain Niazi F; Naseem M; Al Waddani H; Sahibzada HA; Sannam Khan R
    Proteomes; 2017 Aug; 5(3):. PubMed ID: 28783097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.